Читать «Трещина в мироздании» онлайн - страница 199

260

261

J. Savulescu et al., “The Moral Imperative to Continue Gene Editing Research on Human Embryos”, Protein and Cell 6 (2015): 476–479.

262

S. Pinker, “The Moral Imperative for Bioethics”, Boston Globe, August 1, 2015.

263

Hinxton Group, “Statement on Genome Editing Technologies and Human Germline Genetic Modification”, September 3, 2015, www.hinxtongroup.org/Hinxton2015_Statement.pdf.

264

Cyranoski and Reardon, “Chinese Scientists.”

265

D. Cressey, A. Abbott, and H. Ledford, “UK Scientists Apply for License to Edit Genes in Human Embryos”, Nature News, September 18, 2015.

266

Полный их список можно найти в публикации Национальной академии наук, Национальной инженерной академии и Национальной академии медицины США “International Summit on Human Gene Editing”, December 1–3, 2015, www.nationalacademies.org/gene-editing/Gene-Edit-Summit/index.htm.

267

I. Martincorena and P. J. Campbell, “Somatic Mutation in Cancer and Normal Cells”, Science 34 (2015): 1483–1489.

268

M. Porteus, “Therapeutic Genome Editing of Hematopoietic Cells”, презентация на Inserm Workshop 239, CRISPR-Cas9: Breakthroughs and Challenges, Bordeaux, France, April 6–8, 2016.

269

M. Lynch, “Rate, Molecular Spectrum, and Consequences of Human Mutation”, Proceedings of the National Academy of Sciences of the United States of America 107 (2010): 961–968.

270

S. Pinker in P. Skerrett, “Experts Debate: Are We Playing with Fire When We Edit Human Genes?”, STAT News, November 17, 2015.

271

Q. Zhou et al., “Complete Meiosis from Embryonic Stem Cell-Derived Germ Cells In Vitro”, Cell Stem Cell 18 (2016): 330–340; K. Morohaku et al., “Complete In Vitro Generation of Fertile Oocytes from Mouse Primordial Germ Cells”, Proceedings of the National Academy of Sciences of the United States of America 113 (2016): 9021–9026.

272

J. K. Lim et al., “CCR5 Deficiency Is a Risk Factor for Early Clinical Manifestations of West Nile Virus Infection but Not for Viral Transmission”, Journal of Infectious Diseases 201 (2010): 178–185.

273

M. Aidoo et al., “Protective Effects of the Sickle Cell Gene Against Malaria Morbidity and Mortality”, Lancet 359 (2002): 1311–112.

274

E. M. Poolman and A. P. Galvani, “Evaluating Candidate Agents of Selective Pressure for Cystic Fibrosis”, Journal of the Royal Society 4 (2007): 91–98.

275

Такие сопряженные со старческими деменциями мутации остаются в популяции, поскольку они не снижают число потомков человека: в репродуктивном возрасте связанные с ними болезни еще не проявляются.

276

E. S. Lander, “Brave New Genome”, New England Journal of Medicine 373 (2015): 5–8.

277

G. Church, “Should Heritable Gene Editing Be Used on Humans?”, Wall Street Journal, April 10, 2016.

278

C. Funk, B. Kennedy, and E. P. Sciupac, U.S. Public Opinion on the Future Use of Gene Editing. Washington, DC: Pew Research Center, 2016; “Genetic Modifications for Babies”, Pew Research Center, January 28, 2015, www.pewinternet.org/2015/01/29/public-and-scientists-views-on-science-and-society/pi_2015–01–29_science-and-society-03–25.